Bond.az White LogoBond.az Black Logo

Rosenblatt Reiterates Buy Rating for Palantir

Rosenblatt reaffirms Buy rating for Palantir with $225 target. Company visit boosts confidence in long-term growth to $1 trillion market cap.

Jack Scott
ByJack Scott- Senior Editor
|
0

Rosenblatt has reiterated a Buy rating and $225 price target for Palantir Technologies (NASDAQ:PLTR) following a company visit and partner call.

Analysts met with Palantir CFO David Glazer, Chief Architect Akshay Krishnaswamy, and Head of Strategic Initiatives Cary Li at the New York offices. They also held a call with FoxTrot, a key implementation partner.

The firm expressed increased conviction that Palantir can reach a $1 trillion market cap within five years, implying a $415 target. The AIP/Foundry platform was described as an optimizer of multiple large language models.

FoxTrot's business is expected to at least triple this year. Palantir shares are down 24% year-to-date, but a PEG ratio of 0.5 suggests attractive valuation. Gross margin stands at 84% with 68% revenue growth. Bond.az analysis suggests the stock may be overvalued.

More News
Today / 18:50
|
613

Jefferies Raises Eagle Materials Price Target on Infrastructure Demand

Jefferies raised Eagle Materials price target to $200, citing infrastructure demand. Cement volumes strong from projects and data centers.

0
Today / 18:20
|
686

Truist Raises Target Price Target to $130

Truist Securities raises Target price target to $130 after strong Q1 results. Comparable sales up 5.6%, earnings beat estimates.

0
Today / 14:32
|
515

Benchmark Raises Snowflake Target to $200

Benchmark raises Snowflake price target to $200 ahead of earnings, citing strong growth and AI adoption. Stock appears undervalued according to Bond.az analysis.

0
Today / 14:32
|
794

Benchmark raises Payoneer price target to $9

Benchmark raises Payoneer price target to $9 on strong B2B growth and Q1 2026 results. See details and analysis.

0
Today / 13:31
|
519

William Blair Starts Insulet at Outperform

William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.

0
Today / 12:32
|
782

Deutsche Bank upgrades Centene stock on earnings recovery

Deutsche Bank upgrades Centene stock to Buy with a new price target of $80. Bond.az analysis highlights undervaluation. Latest news on Centene.

0
Today / 12:31
|
744

Deutsche Bank upgrades Elevance stock

Deutsche Bank upgraded Elevance Health to Buy with a $498 price target, citing stable managed care market. Strong Q1 results also boost confidence.

0
Today / 12:11
|
262

BMO Raises Israel Chemicals Target Price on Potash

BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.

0
Today / 12:10
|
223

Cantor Fitzgerald raises PANW price target to $285

Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.

0
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
256

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
...